FDA Letter API

Iberia Foods Company of New York, Inc

Letter data

Company
Iberia Foods Company of New York, Inc
Recipient
Eric S. Miller | CEO | Iberia Foods Company of New York, Inc | Iberia Foods Company of New York, Inc | 1900 Linden Boulevard | Brooklyn | , | NY | 11207-6806 | United States
Issue date
2019-03-13
Posted date
Not available
FDA office
Center for Food Safety and Applied Nutrition
Subject
Not available
Product
Not available
CMS ID
435841
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Iberia Foods Company of New York, Inc MARCS-CMS 435841 — March 13, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: United Parcel Service Recipient: Recipient Name Eric S. Miller Recipient Title CEO Iberia Foods Company of New York, Inc Iberia Foods Company of New York, Inc 1900 Linden Boulevard Brooklyn , NY 11207-6806 United States Issuing Office: Center for Food Safety and Applied Nutrition 158-15 Liberty Avenue Jamaica , NY 11433 United States Dear Mr. Miller: The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter NYK-2014-53, issued on July 31, 2014. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ CDR Catherine Beer Director, Compliance Branch Office of Human and Animal Food Operations East Division 1 Content current as of: 03/19/2019